Corporate pilot resource

Corporate pilot closeout checklist

Close a pilot with a clear record of final communications, open follow-ups, attributable observations, and the review conversation.

Copy-ready closeout

Review the assembled record

The preview updates with your completion marks and edits. Unfilled fields retain their prompts. Your draft is not saved after you leave or reload; copy the reviewed text into an organization-approved record.

Closeout text for manual copy

Corporate pilot closeout checklist

Working draft: verify dates, scope, sources, permissions, owners, and next steps with the appropriate people before recording or sharing.

Final communications

[ ] Confirm the close date and the scope agreed for the pilot

  [confirmed close date; agreed scope; documented changes, if any]

[ ] Send the approved closeout communication through the agreed channel

  [approved communication; agreed channel; approval reference]

[ ] Record the communication recipient and date, plus the final materials shared

  [recipient or role; sent date; list of final materials shared]

[ ] State any open items plainly, or record that none were identified; do not imply continuation

  [open items and current status, or confirmed “none identified”]

Outstanding follow-ups

[ ] List each remaining action and its current status

  [action and status for each item, or “no remaining actions identified”]

[ ] Assign an owner and confirmed target or check-in date to each agreed action

  [action; owner; confirmed target/check-in date]

[ ] Record any dependency or unresolved question, and name who will close each loop

  [dependency or question; person responsible for closing the loop]

[ ] If applicable, record that no further action was agreed at closeout

  [confirmation, if discussed; do not assume renewal or future work]

Attributable observations

[ ] Record what was observed or reported, by whom or from which source, when, and during what activity or context

  [observation/report; person or documented source; date; activity and relevant context]

[ ] Keep self-reported reflections, facilitator observations, and interpretation in separate, clearly labeled notes

  [separate attributed reflection; facilitator observation; interpretation, if any]

[ ] Note limitations and what the documented material cannot establish

  [missing context, source limits, or other constraints; avoid conclusions beyond the record]

[ ] Confirm permission and its scope before attributing or sharing any reflection or observation

  [permission status; approved attribution and sharing scope, or not approved]

[ ] Remove sensitive personal or clinical details and check that no unsupported outcome claim is presented as fact

  [privacy and wording review; changes made, if any]

Review conversation

[ ] Invite the appropriate organizational contacts to the review conversation

  [invited contacts or roles; invitation date; agreed channel]

[ ] Review the confirmed scope and activities, then discuss traceable observations with their sources and limits

  [confirmed scope and activities; sources reviewed; limitations discussed]

[ ] Capture feedback and remaining questions, with an owner and confirmed date for each agreed action

  [feedback; questions; agreed action, owner, and confirmed date]

[ ] Record the agreed close of the conversation, including when no further action was agreed; do not presume renewal

  [closeout summary; no further action agreed, if applicable; no renewal assumed]

Record only information that is documented or directly confirmed. Traceability does not establish causation, representativeness, clinical effectiveness, or organizational or business impact. Do not include sensitive personal or clinical details, and do not attribute or share material without confirmed permission.

Back to corporate pilot resources

Evidence and privacy boundary

A record, not an outcome claim

Record only information that is documented or directly confirmed. Traceability does not establish causation, representativeness, clinical effectiveness, or organizational or business impact. Do not include sensitive personal or clinical details, and do not attribute or share material without confirmed permission.

Corporate pilot closeout checklist

Complete a careful, traceable closeout.

Final communications

Outstanding follow-ups

Attributable observations

Review conversation